Stanford Children's Health to Implement Technegas

Cyclopharm Limited (ASX: CYC) is pleased to announce that it has entered into an agreement with Stanford Medicine Children’s Health to implement Technegas® at Lucile Packard Children’s Hospital Stanford. This marks the first dedicated children’s hospital in the United States to adopt Technegas, representing an important milestone in the early stages of the U.S. commercial rollout. Technegas’ estab